摘要
近年来手术及放化疗在食管癌治疗方面取得了一定的进步,但中晚期食管癌的长期生存率未见明显提高。目前,分子靶向治疗已成为食管癌的研究热点。
Ahhough we have made some progress by the application of surgery, chemotherapy and radiotherapy in re- cent years, there is no significant improvement in the long - term survival rate of middle - advanced stage esophageal. Up to now, molecular targeted therapy has become a research focus of esophageal cancer.
出处
《现代肿瘤医学》
CAS
2014年第7期1728-1732,共5页
Journal of Modern Oncology
基金
四川省卫生厅科研项目(编号:100149)
关键词
食管癌
靶向治疗
进展
esophageal cancer
targeted therapy
progress